| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 112, 170-177, Copyright © 1983 by American Society for Investigative Pathology
REGULAR ARTICLES |
DB Chandler, DM Hyde and SN Giri
The sequence of cellular infiltration into interstitial lung tissue subsequent to intratracheal administration of bleomycin was examined in hamsters. Quantitation of lesions following bleomycin treatment showed a transient increase in the percentage of lung involved, which peaked at 21 days and decreased thereafter. Associated with these lesions was a significant increase in interstitial cell profile density at 21 and 28 days. The total number of cell profiles decreased after 28 days. The cellular composition of the lesion was dominated by monocytes, neutrophils, and macrophages in the initial phase of the fibrosis. Subsequently, monocytes were significantly decreased at 21, 28, and 42 days, as compared with the 7-day value. Similarly, neutrophils were significantly decreased at 21 and 28 days, as compared with the 7-day value. In contrast, macrophages were significantly decreased in the initial phase (7 days) of the cellular infiltration and the later phase at 35 and 42 days, as compared with the value at 4 days after treatment. Lesion composition in the later phase exhibited significant increases in fibroblasts and eosinophils, accompanied by a general increase in lymphocytes. It is concluded that bleomycin-induced inflammatory sequela exhibits temporally based changes in cellular composition of the infiltrate and that the temporal changes in cellularity might be one of the determinants in the pathophysiology of pulmonary fibrosis induced by bleomycin.
This article has been cited by other articles:
 |
|
 |
|
  L. Liu, B. Schwartz, Y. Tsubota, E. Raines, H. Kiyokawa, K. Yonekawa, J. M. Harlan, and L. M. Schnapp Cyclin-Dependent Kinase Inhibitors Block Leukocyte Adhesion and Migration J. Immunol., February 1, 2008; 180(3): 1808 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamada, K. Kuwano, T. Maeyama, M. Yoshimi, N. Hamada, J. Fukumoto, K. Egashira, K. Hiasa, K. Takayama, and Y. Nakanishi Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis J. Clin. Pathol., August 1, 2007; 60(8): 916 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cuzzocrea, S. Ronchetti, T. Genovese, E. Mazzon, M. Agostini, R. Di Paola, E. Esposito, C. Muia, G. Nocentini, and C. Riccardi Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation FASEB J, January 1, 2007; 21(1): 117 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kimura, Y. Ishii, K. Yoh, Y. Morishima, T. Iizuka, T. Kiwamoto, Y. Matsuno, S. Homma, A. Nomura, T. Sakamoto, et al. Overexpression of the Transcription Factor GATA-3 Enhances the Development of Pulmonary Fibrosis Am. J. Pathol., July 1, 2006; 169(1): 96 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Kotton, A. J. Fabian, and R. C. Mulligan Failure of Bone Marrow to Reconstitute Lung Epithelium Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 328 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hamada, K. Kuwano, M. Yamada, N. Hagimoto, K. Hiasa, K. Egashira, N. Nakashima, T. Maeyama, M. Yoshimi, and Y. Nakanishi Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice J. Immunol., July 15, 2005; 175(2): 1224 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Inoshima, K. Kuwano, N. Hamada, N. Hagimoto, M. Yoshimi, T. Maeyama, A. Takeshita, S. Kitamoto, K. Egashira, and N. Hara Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L1038 - L1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kimura, Y. Ishii, Y. Morishima, A. Shibuya, K. Shibuya, M. Taniguchi, M. Mochizuki, A. E. Hegab, T. Sakamoto, A. Nomura, et al. Treatment with {alpha}-Galactosylceramide Attenuates the Development of Bleomycin-Induced Pulmonary Fibrosis J. Immunol., May 1, 2004; 172(9): 5782 - 5789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Adachi, M. Suzuki, T. Sugimoto, K. Yorozu, H. Takai, K. Uetsuka, H. Nakayama, and K. Doi Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity Toxicol Pathol, October 1, 2003; 31(6): 665 - 673. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Koslowski, K. Knoch, E. Kuhlisch, D. Seidel, and M. Kasper Cathepsins in bleomycin-induced lung injury in rat Eur. Respir. J., September 1, 2003; 22(3): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Chung, M. M. Monick, N. Y. Hamzeh, N. S. Butler, L. S. Powers, and G. W. Hunninghake Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Endo, S. Oyadomari, Y. Terasaki, M. Takeya, M. Suga, M. Mori, and T. Gotoh Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L313 - L321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-D. WANG, M. YAMAYA, S. OKINAGA, Y.-X. JIA, M. KAMANAKA, H. TAKAHASHI, L.-Y. GUO, T. OHRUI, and H. SASAKI Bilirubin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 406 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Keane, J. A. Belperio, M. D. Burdick, and R. M. Strieter IL-12 attenuates bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L92 - L97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. BORZONE, R. MORENO, R. URREA, M. MENESES, M. OYARZUN, and C. LISBOA Bleomycin-Induced Chronic Lung Damage Does Not Resemble Human Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1648 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Abraham, M. L. Chou, P. George, P. Pooler, A. Zaman, R. C. Savani, and M. Koval Heterocellular gap junctional communication between alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1085 - L1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Maeyama, K. Kuwano, M. Kawasaki, R. Kunitake, N. Hagimoto, and N. Hara Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12 Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1128 - L1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Savani, G. Hou, P. Liu, C. Wang, E. Simons, P. C. Grimm, R. Stern, A. H. Greenberg, H. M. DeLisser, and N. Khalil A Role for Hyaluronan in Macrophage Accumulation and Collagen Deposition after Bleomycin-Induced Lung Injury Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 475 - 484. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yehualaeshet, R. O'Connor, A. Begleiter, J. E. Murphy-Ullrich, R. Silverstein, and N. Khalil A CD36 Synthetic Peptide Inhibits Bleomycin-Induced Pulmonary Inflammation and Connective Tissue Synthesis in the Rat Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 204 - 212. [Abstract] [Full Text]
|
|
|
|
|
|
A. Mishra, N. A. Doyle, and W. J. Martin II Bleomycin-Mediated Pulmonary Toxicity . Evidence for a p53-Mediated Response Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 543 - 549. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Kaminski, J. D. Allard, J. F. Pittet, F. Zuo, M. J. D. Griffiths, D. Morris, X. Huang, D. Sheppard, and R. A. Heller Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis PNAS, February 15, 2000; 97(4): 1778 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Iyer, G. Gurujeyalakshmi, and S. N. Giri Effects of Pirfenidone on Transforming Growth Factor-beta Gene Expression at the Transcriptional Level in Bleomycin Hamster Model of Lung Fibrosis J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 367 - 373. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. Keane, J. A. Belperio, T. A. Moore, B. B. Moore, D. A. Arenberg, R. E. Smith, M. D. Burdick, S. L. Kunkel, and R. M. Strieter Neutralization of the CXC Chemokine, Macrophage Inflammatory Protein-2, Attenuates Bleomycin-Induced Pulmonary Fibrosis J. Immunol., May 1, 1999; 162(9): 5511 - 5518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhao, S. L. Young, and J. C. McIntosh Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L1049 - L1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhao, W. Shi, Y.-L. Wang, H. Chen, P. Bringas Jr., M. B. Datto, J. P. Frederick, X.-F. Wang, and D. Warburton Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L585 - L593. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
